A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-21-063 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) solicits applications for Connecting Underrepresented Populations to Clinical Trials (CUSP2CT), a program that will implement and evaluate multilevel and culturally tailored outreach and education interventions with the primary goal of increasing referral and ultimately, accrual of underrepresented racial/ethnic (R/E) minority populations, to NCI-supported clinical trials (CTs) (National Clinical Trial Network (NCTN), NCI's Community Oncology Research Pro...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 19, 2021 Category: Research Source Type: funding
Register Today for Our Capacity Building Webinar to be Held on October 21
Are you at an institution with little NIH research support? Are you interested in sustaining or increasing research capacity at your institution? If so, then whether you are a researcher or institutional official, you may be interested in joining us for the 2021 Capacity Building for the Future of Biomedical Research Webinar, an official NIH Virtual Seminar on Program Funding and Grants Administration preconference event, on Thursday, October 21, 2021, 1:00 PM to 3:30 PM EDT. Registration is required for the Capacity Building event. Register today, as space is limited!
This webinar will strengthen your knowledge base b...
Source: NIH Extramural Nexus - October 14, 2021 Category: Research Authors: NIH Staff Tags: Top Stories NIH seminar Source Type: funding
Notice of Correction to PAR-21-166 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)"
Notice NOT-CA-21-119 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 23, 2021 Category: Research Source Type: funding
Partnerships for Research and Education in Chemistry (PREC)
Available Formats: HTML: https://www.nsf.gov/pubs/2021/nsf21620/nsf21620.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2021/nsf21620/nsf21620.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf21620Public Comment: This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - September 15, 2021 Category: Science Source Type: funding
Request for Public Comment: Seeking Input on Nationwide AI Research Resource Implementation Plan
This post originally released on the National Library of Medicine’s Musings from the Mezzanine blog.
Guest post by Lynne E. Parker, PhD, Director of the White House National Artificial Intelligence Initiative Office, and Erwin Gianchandani, PhD, National Science Foundation Senior Advisor for Translation, Innovation, and Partnerships
The White House Office of Science and Technology Policy and National Science Foundation are looking for your input to shape the work of the National Artificial Intelligence Research Resource (NAIRR) Task Force. This Task Force is taking on a critically important initiative – building an im...
Source: NIH Extramural Nexus - September 1, 2021 Category: Research Authors: Lynne E. Parker and Erwin Gianchandani Tags: blog Open Mike AI artificial intelligence Request For Information (RFI) Source Type: funding
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-21-057 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) solicits applications for Connecting Underrepresented Populations to Clinical Trials (CUSP2CT), a program that will implement and evaluate multilevel and culturally tailored outreach and education interventions with the primary goal of increasing referral and ultimately, accrual of underrepresented racial/ethnic (R/E) minority populations, to NCI-supported clinical trials (CTs) (National Clinical Trial Network (NCTN), NCI's Community Oncology Research Pro...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 1, 2021 Category: Research Source Type: funding
Collaborative Partnership between Research Centers in Minority Institutions (RCMI) and Alcohol Research Centers (U54 Clinical Trial Optional)
Funding Opportunity RFA-AA-21-015 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U54 applications for the planning and implementation of collaborative partnerships between Research Centers in Minority Institutions (RCMI) and institutions with extensive alcohol research programs, including NIAAA-funded alcohol research centers and consortia (ARC). RCMI are institutions that offer doctorate degrees in the health professions or in a health-related science and have a historical and current commitment to educating underrepresented students, and for institutions that deliver h...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 1, 2021 Category: Research Source Type: funding
Partnerships for Research and Education in Physics (PREP)
Available Formats: HTML: https://www.nsf.gov/pubs/2021/nsf21610/nsf21610.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2021/nsf21610/nsf21610.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf21610Public Comment: This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - September 1, 2021 Category: Science Source Type: funding
Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)
Funding Opportunity PAR-21-282 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and limited-size clinical studies to advance the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and effectivenesting, design verification and validation activities leading to submission of an Investigational Device...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 20, 2021 Category: Research Source Type: funding
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
Funding Opportunity PAR-21-315 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) stud...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 20, 2021 Category: Research Source Type: funding
Multi-Disciplinary Collaborations to Understand Mechanisms of Systemic Immune Signaling and Inflammation in ADRD and its Progression (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-023 from the NIH Guide for Grants and Contracts. Recent findings have raised the hypothesis that systemic immune responses could play direct or indirect roles in brain neurodegeneration leading to AD/ADRD, and has been significantly less studied compared to innate immune mechanisms such as microglia in the brain. This initiative will capitalize on growing interest in the research community and will support partnerships and new collaborations between neuroscientists and immunologists to expand the research base in this area with the long-term goal of bringing more immunology expertise into the ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 6, 2021 Category: Research Source Type: funding
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
Funding Opportunity PAR-21-303 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, or analytics. The overall goal of the program is to catalyze innovation through multidisciplinary research that addresses global health problems, develop an ev...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 4, 2021 Category: Research Source Type: funding
Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-HG-21-033 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NHGRI R25 program is to support educational activities that encourage undergraduates from diverse backgrounds, including those from groups underrepresented in the biomedical workforce, to pursue further training and careers in the scientific, medical, ethical, social and/or legal areas of genomics research. To accomplish the stated over-arching goal, this FOA will support creative educational activi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 3, 2021 Category: Research Source Type: funding
Clinical and Translational Science Award (UM1 Clinical Trial Optional)
Funding Opportunity PAR-21-293 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications for the Clinical and Translational Science Award (CTSA) Program hubs that will be part of a national, collaborative consortium focused on bringing more treatments to more patients more quickly through advancing clinical and translational science (CTS) by (1) developing, demonstrating, and disseminating scientific and operational innovations that improve the efficiency and effectiveness of clinical translation from identification to first-in-human studies to medical practice impleme...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 30, 2021 Category: Research Source Type: funding
Healthy Brain Initiative: Supporting Tribal Partnerships for Implementing the Road Map for Indian Country
Grants for tribal health programs that use strategies from the Road Map for Indian Country to address Alzheimer's Disease and related dementias. Geographic coverage: Nationwide -- National Indian Health Board (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - July 23, 2021 Category: American Health Source Type: funding
